Stock Watch: J&J Q4 Reaction Indicates Pharma Is Falling Out Of Favor
Pharma Needs More Than Modest Sales Growth To Retain Investors
When a sector re-rates and goes out of favor against the backdrop of wider headwinds, even sales growth may not distract investors from greener grass in other sectors.
